Passage Bio logo

Passage Bio Share Price (NASDAQ: PASG)

$7.47

-0.07

(-0.93%)

Live

Last updated on

Check the interactive Passage Bio Stock chart to analyse performance

Passage Bio stock performance

as on August 26, 2025 at 12:29 AM IST

  • Today's Low:$7.35
    Today's High:$7.58

    Day's Volatility :3.03%

  • 52 Weeks Low:$5.12
    52 Weeks High:$26.60

    52 Weeks Volatility :80.74%

Passage Bio Stock Returns

PeriodPassage Bio IncSector (Health Care)Index (Russel 2000)
3 Months
5.28%
6.0%
0.0%
6 Months
-27.21%
-7.2%
0.0%
1 Year
-54.02%
-11.1%
0.0%
3 Years
-81.24%
5.5%
-10.0%

Passage Bio Inc Key Stats

Check Passage Bio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$7.54
Open
$7.31
Today's High
$7.58
Today's Low
$7.35
Market Capitalization
$24.0M
Today's Volume
$47.5K
52 Week High
$26.6
52 Week Low
$5.1239
Revenue TTM
$0.0
EBITDA
$-52.5M
Earnings Per Share (EPS)
$39.4
PE Ratio
0.19
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-88.27%

Stock Returns calculator for Passage Bio Stock including INR - Dollar returns

The Passage Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Passage Bio investment value today

Current value as on today

₹49,904

Returns

₹50,096

(-50.1%)

Returns from Passage Bio Stock

₹54,451 (-54.45%)

Dollar Returns*

₹4,355 (+4.36%)

Indian investors sentiment towards Passage Bio Stock

-47%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Passage Bio Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Passage Bio Inc

  • Name

    Holdings %

  • Orbimed Advisors, LLC

    11.27%

  • Vestal Point Capital LP

    9.77%

  • New Leaf Venture Partners, L.L.C.

    4.00%

  • Erste Asset Management GmbH

    3.94%

  • Vanguard Group Inc

    3.32%

  • TANG CAPITAL MANAGEMENT LLC

    2.40%

Analyst Recommendation on Passage Bio Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Passage Bio(by analysts ranked 0 to 5 stars)

Passage Bio Share Price Target

What analysts predicted

Upside of 693.17%

Target:

$59.25

Current:

$7.47

Passage Bio share price target is $59.25, a slight Upside of 693.17% compared to current price of $7.47 as per analysts' prediction.

Passage Bio Stock Insights

  • Price Movement

    In the last 6 months, PASG stock has moved down by -28.5%
  • PASG vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 116.6%
  • PASG vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 195.3%

Passage Bio Technicals Summary

Sell

Neutral

Buy

Passage Bio is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Passage Bio Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Passage Bio Inc logo
6.95%
-27.21%
-54.02%
-81.24%
-97.55%
Regeneron Pharmaceuticals, Inc. logo
5.52%
-17.35%
-50.85%
-1.12%
-3.68%
Beone Medicines Ltd logo
6.51%
21.35%
57.45%
73.21%
25.84%
Vertex Pharmaceuticals Incorporated logo
-14.26%
-17.97%
-18.13%
40.27%
45.64%
Alnylam Pharmaceuticals, Inc. logo
39.9%
82.53%
68.83%
115.41%
241.51%

About Passage Bio Inc

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Organization
Passage Bio
Employees
60
CEO
Dr. William Chou M.D.
Industry
Health Technology

Key Management of Passage Bio Inc

NameTitle
Dr. William Chou M.D.
President, CEO & Director
Ms. Kathleen Borthwick
Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Edgar B. Cale Esq., J.D.
General Counsel & Company Secretary
Dr. Sue Browne Ph.D.
Chief Scientific Officer
Mr. Stuart M. Henderson
Chief Business Officer
Eden Fucci
Senior Vice President of Technical Operations
Dr. Karl Whitney Ph.D.
Senior Vice President of Global Regulatory Affairs

Important FAQs about investing in PASG Stock from India :

What is Passage Bio share price today?

Passage Bio share price today is $7.47 as on . Passage Bio share today touched a day high of $7.58 and a low of $7.35.

What is the 52 week high and 52 week low for Passage Bio share?

Passage Bio share touched a 52 week high of $26.60 and a 52 week low of $5.12. Passage Bio stock price today i.e. is trending at $7.47, lower by 71.92% versus the 52 week high.

How to invest in Passage Bio Stock (PASG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Passage Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Passage Bio Shares that will get you 0.2008 shares as per Passage Bio share price of $7.47 per share as on August 26, 2025 at 12:29 AM IST.

What is the minimum amount required to buy Passage Bio Stock (PASG) from India?

Indian investors can start investing in Passage Bio (PASG) shares with as little as ₹87.554 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.54 in Passage Bio stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Passage Bio share’s latest price of $7.47 as on August 26, 2025 at 12:29 AM IST, you will get 1.3387 shares of Passage Bio. Learn more about fractional shares .

What are the returns that Passage Bio has given to Indian investors in the last 5 years?

Passage Bio stock has given -97.55% share price returns and 18.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?